MX2008013332A - Deteccion de proteinas de celulas neoplasicas circulantes. - Google Patents

Deteccion de proteinas de celulas neoplasicas circulantes.

Info

Publication number
MX2008013332A
MX2008013332A MX2008013332A MX2008013332A MX2008013332A MX 2008013332 A MX2008013332 A MX 2008013332A MX 2008013332 A MX2008013332 A MX 2008013332A MX 2008013332 A MX2008013332 A MX 2008013332A MX 2008013332 A MX2008013332 A MX 2008013332A
Authority
MX
Mexico
Prior art keywords
protein
immunoassay
cancer cells
blood
egfr
Prior art date
Application number
MX2008013332A
Other languages
English (en)
Spanish (es)
Inventor
Robert M Lorence
Original Assignee
Wellstat Biologics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellstat Biologics Corp filed Critical Wellstat Biologics Corp
Publication of MX2008013332A publication Critical patent/MX2008013332A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MX2008013332A 2006-04-18 2007-04-18 Deteccion de proteinas de celulas neoplasicas circulantes. MX2008013332A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74501606P 2006-04-18 2006-04-18
PCT/US2007/066857 WO2007121465A2 (en) 2006-04-18 2007-04-18 Detection of proteins from circulating neoplastic cells

Publications (1)

Publication Number Publication Date
MX2008013332A true MX2008013332A (es) 2008-11-10

Family

ID=38610457

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008013332A MX2008013332A (es) 2006-04-18 2007-04-18 Deteccion de proteinas de celulas neoplasicas circulantes.

Country Status (6)

Country Link
US (1) US8012480B2 (cg-RX-API-DMAC7.html)
EP (1) EP2008102A4 (cg-RX-API-DMAC7.html)
JP (1) JP5025724B2 (cg-RX-API-DMAC7.html)
CA (1) CA2647843A1 (cg-RX-API-DMAC7.html)
MX (1) MX2008013332A (cg-RX-API-DMAC7.html)
WO (1) WO2007121465A2 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4798801B2 (ja) * 2004-10-06 2011-10-19 ウェルスタット バイオロジクス コーポレイション 循環する癌細胞におけるHer−2/neuタンパク質のレベルの上昇の検出および処置
EP2145188A4 (en) * 2007-04-19 2010-06-30 Wellstat Biologics Corp DETECTION OF HER2 / NEU PROTEIN FROM UNISISIONED CIRCULATING CANCER CELLS AND TREATMENT
US11072655B2 (en) 2008-01-15 2021-07-27 The Board Of Trustees Of The Leland Stanford Junior University Markers of acute myeloid leukemia stem cells
CA2711370C (en) 2008-01-15 2017-06-13 The Board Of Trustees Of The Leland Stanford Junior University Markers of acute myeloid leukemia stem cells
PT3056515T (pt) 2008-01-15 2019-07-19 Univ Leland Stanford Junior Métodos para manipulação da fagocitose mediada por cd47
WO2011162904A2 (en) * 2010-05-24 2011-12-29 Marek Malecki Multidomain biotags for cancer detection, diagnosis and therapy and methods of their use priority statement
WO2012051390A1 (en) * 2010-10-14 2012-04-19 Veridex, Llc Methods and kits for the detection of circulating tumor cells in pancreatic patients using polyspecific capture and cocktail detection reagents
CN102680456B (zh) 2011-03-16 2015-07-08 北京联众泰克科技有限公司 一种电化学发光免疫测定方法
CN107315086B (zh) 2011-06-29 2019-09-10 中央研究院 使用表面涂层对生物物质的捕获、纯化和释放
WO2013036620A1 (en) * 2011-09-06 2013-03-14 Becton, Dickinson And Company Methods and compositions for cytometric detection of rare target cells in a sample
WO2014147631A1 (en) 2013-03-22 2014-09-25 Natco Pharma Limited Formulation comprising gefitinib as oral suspension
TW201623605A (zh) 2014-04-01 2016-07-01 中央研究院 用於癌症診斷及預後之方法及系統
US10112198B2 (en) 2014-08-26 2018-10-30 Academia Sinica Collector architecture layout design
EP3194616B1 (en) * 2014-09-18 2020-07-29 AdnaGen GmbH Mrna and/or protein of ercc1 isoform 3 for use in diagnosing a resistance against a therapeutic agent and method for diagnosing a resistance against a therapeutic agent using said mrna and/or protein
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
CN109991410B (zh) * 2017-12-29 2022-07-05 上海白泽医学检验所有限公司 一种含抗cd45单抗的组合物及其使用方法
CN114487059B (zh) * 2021-12-29 2022-11-25 苏州大学 一种电化学发光免疫传感器及其制备和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0494135B1 (en) * 1989-09-29 1996-04-10 Oncogene Science, Inc. Human "neu" related protein p100 and use of the same for detecting preneoplastic or neoplastic cells in a human
ES2285713T3 (es) * 1995-06-07 2007-11-16 Bioveris Corporation Enzimoinmunoanalisis electroquimioluminiscente.
US6960449B2 (en) * 1999-02-10 2005-11-01 Cell Works Diagnostics, Inc. Class characterization of circulating cancer cells isolated from body fluids and methods of use
US7537938B2 (en) 2000-04-28 2009-05-26 Monogram Biosciences, Inc. Biomarker detection in circulating cells
BR0207290A (pt) * 2001-02-16 2005-06-07 Immunivest Corp Método para analisar um paciente quanto à presença de uma malignidade, célula maligna isolada das células cultivadas, vacina de tumor, molécula associada com diátese de tumor alterada, métodos para determinar alterações em moléculas associadas com diátese de tumor como um meio para predizer a eficácia da terapia, como um meio para analisar dosagem apropriada para terapia, como um meio para monitorar eficácia da terapia, como um meio para analisar progressão de câncer, para realizar uma biópsia de corpo inteiro em um paciente, e para identificar alterações em uma célula de tumor circulante relativamente a células presentes numa massa de tumor in situ, e, kit de teste para analisar uma amostra de paciente quanto à presença de uma célula maligna não-hematopoiética
IL161357A0 (en) * 2001-10-26 2004-09-27 Immunivest Corp Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
EP1516186B1 (en) * 2002-06-26 2010-02-17 University Of Louisville Research Foundation, Inc. A method for the detection of apoptosis
HUP0600340A3 (en) 2002-07-15 2011-06-28 Genentech Inc Methods for identifying tumors that are responsive to treatment with anti-erbb2 antibodies
BRPI0408928A (pt) * 2003-04-01 2006-09-12 Monogram Biosciences Inc métodos para determinar uma situação de doença em um paciente, uma situação apoptótica de células em uma amostra, e uma situação de um cáncer em um paciente
JP2007502983A (ja) * 2003-08-15 2007-02-15 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション がん検出のための多因子アッセイ
JP5422120B2 (ja) * 2004-05-27 2014-02-19 ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド,ア ボディー コーポレイト 癌患者による上皮成長因子受容体阻害薬に対する臨床転帰の予測方法
JP2008523784A (ja) * 2004-09-14 2008-07-10 ジョン ウェイン キャンサー インスティチュート 体液中癌細胞の検出
JP4798801B2 (ja) 2004-10-06 2011-10-19 ウェルスタット バイオロジクス コーポレイション 循環する癌細胞におけるHer−2/neuタンパク質のレベルの上昇の検出および処置

Also Published As

Publication number Publication date
WO2007121465A2 (en) 2007-10-25
CA2647843A1 (en) 2007-10-25
WO2007121465A3 (en) 2008-06-19
US8012480B2 (en) 2011-09-06
US20090098138A1 (en) 2009-04-16
WO2007121465B1 (en) 2008-09-12
JP5025724B2 (ja) 2012-09-12
EP2008102A4 (en) 2009-07-08
JP2009534667A (ja) 2009-09-24
EP2008102A2 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
US8012480B2 (en) Detection of proteins from circulating neoplastic cells
Sharma et al. Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma
JP4798801B2 (ja) 循環する癌細胞におけるHer−2/neuタンパク質のレベルの上昇の検出および処置
Patten et al. CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment
Lu et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages
CA2684265A1 (en) Detection of elevated levels of her-2/neu protein from non-isolated circulating cancer cells and treatment
JP2009538415A (ja) 循環癌細胞におけるステロイド受容体の検出および処置
WO2010066858A1 (en) Methods for the treatment and the prognosis of cancer
MX2008013333A (es) Deteccion de celulas endoteliales circulantes.
US20210231659A1 (en) Detection and isolation of myeloid-derived suppressor cell subpopulations
TW202127033A (zh) 癌幹細胞之生物標誌
US20140302526A1 (en) Zap-70 detection in chronic lymphocytic leukemia
CA2798250A1 (en) Method of obtaining circulating cancer cell populations, associated cellular compositions and methods of using same
Ciprut et al. Neuro-oncology advances
TWI727132B (zh) 肺癌幹細胞之生物標誌
Wang et al. Recent Developments in Application of Multiparametric Flow Cytometry in CAR-T Immunotherapy
Meesters-Ensing et al. Profiling the immune tumor microenvironment of pediatric brain tumors with cavitron ultrasonic surgical aspirator (CUSA)-derived tissue fragments
Burylo et al. Enrichment of circulating endothelial cells by CD34 microbeads followed by enumeration using flow cytometry
CN121994683A (zh) 多发性骨髓瘤循环浆细胞流式检测方法及系统
CN112852821A (zh) 一种cd81的适配体及其应用
Pang Liquid biopsy of extracellular vesicle-based biomarkers for prostate cancer early diagnosis and risk stratification
Arcimowicz The role of B lymphocytes in immune response in non-small cell lung cancer
HK1103439B (en) Detection of elevated levels of her-2/neu protein on circulating cancer cells and treatment

Legal Events

Date Code Title Description
FG Grant or registration